TitletownTech — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Oculogicaoculogica.cominMay 2024
Oculogica develops FDA-cleared concussion assessment devices that use proprietary eye-tracking technology to measure abnormal eye movements caused by traumatic brain injury.
BiotechDigital HealthHealthtechMedical DevicesNew York, US
Rosina Samadani(Executive Officer, Director)Uzma Samadani(Director)inPratipatti Laxminarain(Director)Jason Huang(Director)Robert Ritlop(Executive Officer)Bilal Khan(Director)
Board seatJill Enos· per SEC Form D
Co-investorsColle Capital PartnersSeraph GroupGolden Seeds
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.